Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory R Pond

Showing results (171-180 of 255) with videos related to

Pageof 26
Sort By:
Head & Neck|April 19, 2018
Pretreatment neurocognitive function and self-reported symptoms in patients with newly diagnosed head and neck cancer compared with noncancer cohortLori J Bernstein, Gregory R Pond, Hui K Gan, et al.
The American Journal of Pathology|December 26, 2003
Defining a 0.5-mb region of genomic gain on chromosome 6p22 in bladder cancer by quantitative-multiplex polymerase chain reactionAndrew J Evans, Brenda L Gallie, Michael A S Jewett, et al.
Clinical Genitourinary Cancer|May 3, 2014
Concurrent chemoradiotherapy for men with locally advanced penile squamous cell carcinomaGregory R Pond, Matthew I Milowsky, Michael P Kolinsky, et al.
JAMA Oncology|June 13, 2024
Stereotactic Ablative Radiotherapy for Gynecological Oligometastatic and Oligoprogessive TumorsElysia K Donovan, Simon S Lo, Sushil Beriwal, et al.
Future Science OA|August 28, 2025
Prognostic factors in advanced incurable HNSCC patients on palliative-intent immunotherapy-based regimenZainab Al Maqrashi, Michelle Bradbury, Sze Wah Samuel Chan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2007
Phase I/II trial of erlotinib and cisplatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: a Princess Margaret Hospital phase II consortium and National Cancer Institute of Canada Clinical Trials Group StudyLillian L Siu, Denis Soulieres, Eric X Chen, et al.
NPJ Breast Cancer|March 6, 2020
The LISA randomized trial of a weight loss intervention in postmenopausal breast cancerPamela J Goodwin, Roanne J Segal, Michael Vallis, et al.
Breast Cancer Research and Treatment|April 27, 2007
A Phase 2 study of perifosine in advanced or metastatic breast cancerNatasha B Leighl, Susan Dent, Mark Clemons, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 21, 2007
Phase II trial of sorafenib in patients with recurrent or metastatic squamous cell carcinoma of the head and neck or nasopharyngeal carcinomaChristine Elser, Lillian L Siu, Eric Winquist, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 3, 2022
Vasomotor symptoms in early breast cancer-a "real world" exploration of the patient experienceKatherine Marie Cole, Mark Clemons, Mashari Alzahrani, et al.
Pageof 26

Showing results (171-180 of 255) with videos related to

Sort By:
Pageof 26
Head & Neck|April 19, 2018
Pretreatment neurocognitive function and self-reported symptoms in patients with newly diagnosed head and neck cancer compared with noncancer cohortLori J Bernstein, Gregory R Pond, Hui K Gan, et al.
The American Journal of Pathology|December 26, 2003
Defining a 0.5-mb region of genomic gain on chromosome 6p22 in bladder cancer by quantitative-multiplex polymerase chain reactionAndrew J Evans, Brenda L Gallie, Michael A S Jewett, et al.
Clinical Genitourinary Cancer|May 3, 2014
Concurrent chemoradiotherapy for men with locally advanced penile squamous cell carcinomaGregory R Pond, Matthew I Milowsky, Michael P Kolinsky, et al.
JAMA Oncology|June 13, 2024
Stereotactic Ablative Radiotherapy for Gynecological Oligometastatic and Oligoprogessive TumorsElysia K Donovan, Simon S Lo, Sushil Beriwal, et al.
Future Science OA|August 28, 2025
Prognostic factors in advanced incurable HNSCC patients on palliative-intent immunotherapy-based regimenZainab Al Maqrashi, Michelle Bradbury, Sze Wah Samuel Chan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2007
Phase I/II trial of erlotinib and cisplatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: a Princess Margaret Hospital phase II consortium and National Cancer Institute of Canada Clinical Trials Group StudyLillian L Siu, Denis Soulieres, Eric X Chen, et al.
NPJ Breast Cancer|March 6, 2020
The LISA randomized trial of a weight loss intervention in postmenopausal breast cancerPamela J Goodwin, Roanne J Segal, Michael Vallis, et al.
Breast Cancer Research and Treatment|April 27, 2007
A Phase 2 study of perifosine in advanced or metastatic breast cancerNatasha B Leighl, Susan Dent, Mark Clemons, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 21, 2007
Phase II trial of sorafenib in patients with recurrent or metastatic squamous cell carcinoma of the head and neck or nasopharyngeal carcinomaChristine Elser, Lillian L Siu, Eric Winquist, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 3, 2022
Vasomotor symptoms in early breast cancer-a "real world" exploration of the patient experienceKatherine Marie Cole, Mark Clemons, Mashari Alzahrani, et al.
Pageof 26